in Berlin the week after next (March 27-30, 2023)! Take your chance and apply now!
-
Great news! We still have two free places for our RNA-Seq workshop in Berlin the week after next (March 27-30, 2023)! Take your chance and apply now!
-
RNA-Seq Data Analysis Workshop - Join us in Berlin, Germany from March 27-30, 2023!
Dear all,
We are excited to announce the RNA-Seq Data Analysis Workshop taking place in Berlin, Germany from March 27th to 30th, 2023. This hands-on event is designed for biologists, molecular biologists, molecular pathologists, researchers in the human genetics field, and those working in the clinical diagnostics field. The workshop is an opportunity for you to refine your RNA sequencing data analysis skills and network with industry experts.
The workshop will cover the latest techniques and best practices in RNA-Seq data analysis, providing you with hands-on experience and the knowledge you need to succeed in your field. Whether you're working with NGS or looking to expand your expertise, this workshop is a valuable investment in your future.
For more information and to register, visit the link https://www.ecseq.com/workshops/work...-data-analysis.
Don't miss out on this opportunity to enhance your abilities and network with fellow professionals in the field. We hope to see you in Berlin!
Last edited by ecSeq Bioinformatics; 02-13-2023, 01:08 AM.
-
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...Today, 06:46 AM -
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM
Leave a comment: